[go: up one dir, main page]

CO5180541A1 - Inhibidores de proteasa del tipo de 1,3-diaminocetonas con anillo de 8-14 miembros - Google Patents

Inhibidores de proteasa del tipo de 1,3-diaminocetonas con anillo de 8-14 miembros

Info

Publication number
CO5180541A1
CO5180541A1 CO99078651A CO99078651A CO5180541A1 CO 5180541 A1 CO5180541 A1 CO 5180541A1 CO 99078651 A CO99078651 A CO 99078651A CO 99078651 A CO99078651 A CO 99078651A CO 5180541 A1 CO5180541 A1 CO 5180541A1
Authority
CO
Colombia
Prior art keywords
alkyl
group
het
cycloalkyl
mfi
Prior art date
Application number
CO99078651A
Other languages
English (en)
Inventor
Jr Robert Wells Marquis
Daniel Frank Veber
Original Assignee
Smithkline Beechman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beechman Corp filed Critical Smithkline Beechman Corp
Publication of CO5180541A1 publication Critical patent/CO5180541A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D225/00—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
    • C07D225/02—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom not condensed with other rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Un compuesto de fórmula I:<EMI FILE="99078651_1" ID="1" IMF=JPEG >en la que:A se selecciona entre el grupo que consta de: C(O) y CH(OH);R1 se selecciona entre el grupo que consta de:<EMI FILE="99078651_2" ID="2" IMF=JPEG >R2 se selecciona entre el grupo que consta de: H, alquilo C1-6, cicloalquil C3-6-alquilo C0-6, Ar-alquilo C0-6, Het-alquilo C0-6, R9C(O)-, R9C(S)-, R9SO2-, R9OC(O)-, R9R12NC(O)-, R9R12NC(S)-, R12HNCH(R12)C(O)-, R9OC(O)NR12CH(R12)C(O)-, adamantil-C(O)-, o<EMI FILE="99078651_3" ID="3" IMF=JPEG >R" se selecciona entre el grupo que consta de: H, alquilo C1-6, Ar-alquilo C0-6, y Het-alquilo C0-6.R"´ se selecciona entre el grupo que consta de: H, alquilo C1-6, cicloalquil C3-6-alquilo C0-6, Ar-alquilo C0-6, y Het-alquilo C0-6,R3 y R8 se seleccionan independientemente entre el grupo que consta de: H, alquenilo C2-6, alquinilo C2-6, Het, Ar o alquilo C1-6 opcionalmenre sustituido con OR13, SR13, NR132, R13NC(O)OR5, CO2R13, CO2NR132, N(C=NH)NH2, Het y Ar;R4 se selecciona entre el grupo que consta de: H, alquilo C1-6, cicloalquil C3-6-alquilo C0-6, Ar-alquilo C0-6, Het-alquilo C0-6, R5C(O)-, R5C(S)-, R5SO2-, R5OC(O)-, R5R14NC(O)-, R5R14NC(S)-, R14HNCH(R14)C(O)- y R5OC(O)NR14CH(R14)C(O)-;R5, R9 y R10 se seleccionan independientemente entre el grupo que consta de:alquilo C1-6, cicloalquiI C3-6-alquilo C0-6, Ar-alquilo C0-6, y Het-alquilo C0-6 ;R6 se selecciona entre el grupo que consta de: H, alquilo C1-6, Ar-alquilo C0-6 y Het-alquilo C0-6 ;R7 se selecciona entre el grupo que consta de: H, alquilo C1-6, cicloalquil C3-6-alquilo C0-6, Ar-alquilo C0-6, Het-alquilo C0-6, R10C(O)-, R10C(S)-, R10SO2-, R10OC(O)-, R10R15NC(O)-, R10R15NC(S)-, R15HNCH(R15)C(O)- y R10OC(O)NR15CH(R15)C(O)-;oR6 y R7 se conectan para formar un anillo de pirrolidina, piperidina o morfolina; ...
CO99078651A 1998-12-23 1999-12-16 Inhibidores de proteasa del tipo de 1,3-diaminocetonas con anillo de 8-14 miembros CO5180541A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11414398P 1998-12-23 1998-12-23

Publications (1)

Publication Number Publication Date
CO5180541A1 true CO5180541A1 (es) 2002-07-30

Family

ID=22353596

Family Applications (1)

Application Number Title Priority Date Filing Date
CO99078651A CO5180541A1 (es) 1998-12-23 1999-12-16 Inhibidores de proteasa del tipo de 1,3-diaminocetonas con anillo de 8-14 miembros

Country Status (9)

Country Link
EP (1) EP1140897A4 (es)
JP (1) JP2002533452A (es)
AR (1) AR021970A1 (es)
AU (1) AU2713100A (es)
CO (1) CO5180541A1 (es)
DZ (1) DZ2976A1 (es)
HK (1) HK1041690A1 (es)
PE (1) PE20001355A1 (es)
WO (1) WO2000039115A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030144175A1 (en) 1998-12-23 2003-07-31 Smithkline Beecham Corporation Protease inhibitors
US6534498B1 (en) 1999-11-10 2003-03-18 Smithkline Beecham Corporation Protease inhibitors
JP2003513971A (ja) 1999-11-10 2003-04-15 スミスクライン・ビーチャム・コーポレイション プロテア−ゼ阻害剤
EP1232154A4 (en) 1999-11-10 2004-06-23 Smithkline Beecham Corp PROTEASE INHIBITORS
AU4344101A (en) 2000-03-21 2001-10-03 Smithkline Beecham Corp Protease inhibitors
US6982263B2 (en) 2001-06-08 2006-01-03 Boehringer Ingelheim Pharmaceuticals, Inc. Nitriles useful as reversible inhibitors of cysteine proteases
WO2003075853A2 (en) 2002-03-08 2003-09-18 Bristol-Myers Squibb Company Cyclic derivatives as modulators of chemokine receptor activity
EP1796793A4 (en) * 2004-09-07 2009-08-05 Smithkline Beecham Corp NEW CONNECTIONS
CN101137412B (zh) * 2005-01-13 2012-11-07 布里斯托尔-迈尔斯·斯奎布公司 用作凝血因子XIa抑制剂的取代的二芳基化合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DZ2285A1 (fr) * 1996-08-08 2002-12-25 Smithkline Beecham Corp Inhibiteurs de protéase de la cystéine.
CN1255162A (zh) * 1997-05-08 2000-05-31 史密丝克莱恩比彻姆公司 蛋白酶抑制剂

Also Published As

Publication number Publication date
AU2713100A (en) 2000-07-31
AR021970A1 (es) 2002-09-04
EP1140897A1 (en) 2001-10-10
PE20001355A1 (es) 2001-01-28
JP2002533452A (ja) 2002-10-08
HK1041690A1 (zh) 2002-07-19
WO2000039115A1 (en) 2000-07-06
EP1140897A4 (en) 2002-04-03
DZ2976A1 (fr) 2004-03-15

Similar Documents

Publication Publication Date Title
DE60015927D1 (en) Phenylharnstoff und phenylthioharnstoffderivate
AR045782A2 (es) Derivados de piperidina que tienen actividad farmaceutica
CO5261626A1 (es) Glutarimidas sustituidas, su preparacion, medicamentos que las contienen, y uso de las mismas para la fabricacion de medicamentos, especialemente inmunomoduladores, como asi tambien inhibidores de angiopatias y/o enfermedades hematologicas/oncologica
AR029216A1 (es) Compuestos inhibidores no peptidicos de la union celular dependiente de vla-4 utiles en el tratamiento de enfermedades inflamatorias, autoinmunes y respiratorias; composicion farmaceutica y procedimiento de tratamiento
NZ511394A (en) N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
CO4650042A1 (es) Derivados de 6-fenilpiridil-2-amina
ATE404538T1 (de) Tetrahydropyranylcyclopentyltetrahydroisochino- linmodulatoren der chemokinrezeptoraktivität
SI1534678T1 (sl) Plevromutilinski derivati kot antimikrobna sredstva
CO4920225A1 (es) 2-amino-6-(4-fenoxi-2-sustituido)-piridinas sustituidas
ATE175661T1 (de) Benzamid-derivate als vasopressin-antagonisten
BR0004535A (pt) Compostos, e, uso dos mesmos.
CO5180541A1 (es) Inhibidores de proteasa del tipo de 1,3-diaminocetonas con anillo de 8-14 miembros
ES2038678T3 (es) Procedimiento para la preparacion de n-(2-alquil-3-mercapto-glutaril)-alfamino-acidos.
DE60318826D1 (de) Alkoxypyridinderivate
CO4950553A1 (es) Compuestos de 7-tetrahidroisoquinolinas y procedimiento para su preparacion
CO4990965A1 (es) Derivados de 1,3,8-triazaspiro(4,5)decan-4-ona to que los contiene y un proceso para la preparacion de es- tos derivados
PE20040750A1 (es) Derivados de n-(1-acetilpiperidin-4-il)-4-benzidril-2-isopropilpiperazin-1-carboxamida como inhibidores de 17beta-hidroxiesteroide deshidrogenasa de tipo 3
CO5140104A1 (es) Derivados de mevinolina y preparacion farmaceuticas que los contienen
TR200200360T2 (tr) Antibakteriyel aktif maddeler.
AR035451A1 (es) Derivados de beta-carbolina, su uso para la fabricacion de un medicamento para el tratamiento de la depresion, ansiedad y desordenes bipolares, una composicion farmaceutica y una combinacion.
ATE333457T1 (de) Zyklische gmp-spezifische phosphodiesteraseinhibitoren
HRP20070286T3 (en) Substituted diketopiperazines and their use as oxytocyn antagonists
PE47296A1 (es) Nuevo uso de derivado de indol
CO5140099A1 (es) Ciertas caprolactamas sustituidas, composiciones farmaceuticas que las contienen, y su uso en el tratamiento de tumores
CO5271679A1 (es) Inhibidores de proteasa 7-14 miembros

Legal Events

Date Code Title Description
FA Application withdrawn